FINWIRES · TerminalLIVE
FINWIRES

Transat航空宣布2026-27冬季蒙特婁航線新增阿魯巴、巴貝多和卡波聖盧卡斯航線。

By

-- Transat A.T (TRZ.TO) 週一宣布，將在其 2026-2027 年冬季航班時刻表中新增三條從蒙特婁出發的陽光度假目的地航線。 新航線包括阿魯巴的奧蘭傑斯塔德、巴貝多的布里奇頓以及墨西哥的聖何塞德爾卡沃。飛往聖荷西德爾卡沃的航班將於 12 月 10 日開通，每週一班；飛往奧蘭傑斯塔德的航班將於 12 月 12 日開通，每週一班；而飛往布里奇頓的航班將於 12 月 13 日開通，每週兩班。 「市場對陽光度假目的地的需求仍然強勁，這三條從蒙特利爾出發的新航線使我們能夠透過拓展航線網絡來滿足這一需求。透過新增阿魯巴、巴貝多和洛斯卡沃斯航線，我們將繼續執行以多元化和優化南部航線網絡為核心的策略，從而更好地服務我們的客戶。」首席營收長 Sebastian Ponceian 表示。 這些航班現已開放預訂，但航班時刻表可能會根據批准情況和機場空位情況而有所調整。加拿大越洋航空補充道，將在未來幾週內繼續公佈其完整的冬季航班計劃的更多細節。 加拿大越洋航空的股票在多倫多證券交易所收盤上漲0.02美元，至2.63美元。

Price: $2.60, Change: $-0.01, Percent Change: -0.38%

Related Articles

Asia

Ora Banda Mining Appoints Chair-elect

Ora Banda Mining (ASX:OBM) has appointed John Richards as chair-elect, with plans for him to assume the role following the retirement of current Chair Peter Mansell at the company's annual general meeting in November, according to a Tuesday filing with the Australian bourse.Richards is currently non-executive chair of Sandfire Resources (ASX:SFR) and lead independent non-executive director of Sheffield Resources (ASX:SFX), the filing added.

$ASX:OBM$ASX:SFR$ASX:SFX
Research

Research Alert: Universal Health Services: Q1 Eps Tops Estimates

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:UHS delivered solid Q1 results, with adjusted EPS of $5.62 (up 16.1% Y/Y), $0.16 above consensus, while revenue grew 9.6% to $4.495B due to higher prices despite modest patient volumes. Same-facility acute care revenue increased 8.2% on flat adjusted admissions but 6.3% growth in revenue per admission, while behavioral health saw 1.2% admission growth and 7.3% revenue growth. We think the $835M Talkspace acquisition may expand UHS's virtual behavioral health capabilities and broaden payor mix. Management expects the deal to close in Q3. Operating cash flow improved 11.7% to $402M, and UHS repurchased $127.3M in stock, though adjusted EBITDA margin compressed 20 bps to 14.4% on higher operating expenses. We think behavioral health staffing challenges persist but expect the Talkspace integration to create growth opportunities.

$UHS
Research

Research Alert: Cls Q1: Blistering Fy 26 Guidance And Cpo Win Tempered By Capital Demands

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:Q1 revenues of $4.05B (+53%) and adjusted EPS of $2.16 (+80%) both exceeded guidance on accelerating hyperscaler demand. Adjusted operating margin reached a record 8.0%, due to higher-value CCS offerings, which grew 76% to $3.24B, with segment margin expanding to 8.6%. The company secured a new CPO switch program with a hyperscaler customer expected to ramp in 2027, and we expect more color tomorrow. Management raised 2026 guidance to $19.0B revenue (from $17.0B) and $10.15 adjusted EPS (from $8.75), representing over $6.5B in revenue growth. Stronger growth is anticipated for 2027 based on improved customer visibility and new program wins. The company enlarged its balance sheet by upsizing its credit facility to $2.5B, with revolver capacity increased to $1.75B. FCF of $137.9M remained robust despite elevated capex of $218.4M to support capacity expansion. Share buybacks slowing, FCF guidance lagging, and a +50% month may be contributing to the after-hours selloff.

$CLS